Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gene C. Clark"'
Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis.
Autor:
William T Budd, Sarah J Seashols-Williams, Gene C Clark, Danielle Weaver, Valerie Calvert, Emanuel Petricoin, Ema A Dragoescu, Katherine O'Hanlon, Zendra E Zehner
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0142373 (2015)
MicroRNAs (miRs) are a novel class of small RNA molecules, the dysregulation of which can contribute to cancer. A combinatorial approach was used to identify miRs that promote prostate cancer progression in a unique set of prostate cancer cell lines,
Externí odkaz:
https://doaj.org/article/93ff8048340f42859bb0c4201302ee38
Publikováno v:
International Journal of Molecular Sciences; Volume 18; Issue 6; Pages: 1281
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Prostate cancer is the most common non-cutaneous cancer among men; yet, current diagnostic methods are insufficient, and more reliable diagnostic markers need to be developed. One answer that can bridge this gap may lie in microRNAs. These small RNA
Autor:
Katherine O’Hanlon, Zendra E. Zehner, Gene C. Clark, Valerie S. Calvert, William T. Budd, Danielle E. Weaver, Ema Dragoescu, Emanuel F. Petricoin, Sarah J. Seashols-Williams
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0142373 (2015)
PLoS ONE
PLoS ONE
MicroRNAs (miRs) are a novel class of small RNA molecules, the dysregulation of which can contribute to cancer. A combinatorial approach was used to identify miRs that promote prostate cancer progression in a unique set of prostate cancer cell lines,
Autor:
William T. Budd, Zendra E. Zehner, Gene C. Clark, R Daniel, Sarah J. Seashols-Williams, Qianni Wu, Ema Dragoescu
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0159601 (2016)
PLoS ONE
PLoS ONE
Identification of dysregulated microRNAs (miRNAs) in prostate cancer is critical not only for diagnosis, but also differentiation between the aggressive and indolent forms of the disease. miR-9 was identified as an oncomiR through both miRNA panel RT